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Abstract
Background: Obese individuals differ in their risk of developing metabolic and cardiovascular complications
depending on fat distribution (subcutaneous versus visceral) and adipose tissue (AT) phenotype (hyperplasic versus
hypertrophic). However, the exact mechanisms which determine whether an obese individual is metabolically
healthy or unhealthy are not clear, and analyses of the underlying pathomechanisms are limited by the lack of
suitable in vivo models in which metabolically healthy versus metabolically unhealthy AT accumulation can be
specifically induced. In the current study, we aimed to establish a protocol for the use of zebrafish as a model for
obesity-related metabolically healthy versus metabolically unhealthy AT accumulation.
Methods: We overfed adult male zebrafish of the AB strain with normal fat diet (NFD) or high fat diet (HFD) for 8
weeks and compared parameters related to obesity, i.e. body weight, body mass index, condition index and body
fat percentage, to control zebrafish fed under physiological conditions. In addition, we investigated the presence of
early obesity-related metabolic alterations by quantifying blood glucose levels, plasma triglyceride and cholesterol
levels, and by assessing ectopic lipid accumulation in the liver of zebrafish. Finally, we determined gene expression
levels of marker genes related to lipid metabolism, inflammation and fibrosis in visceral AT and liver.
Results: We show that 8-weeks overfeeding with either NFD or HFD leads to a significant increase in body weight
and AT mass compared to controls. In contrast to NFD-overfed zebrafish, HFD-overfed zebrafish additionally
present metabolic alterations, e.g. hyperglycemia and ectopic lipid accumulation in the liver, and a metabolically
unhealthy AT phenotype with adipocyte hypertrophy especially in the visceral AT depot, which is accompanied by
changes in the expression of marker genes for lipid metabolism, inflammation and fibrosis.
Conclusions: In summary, we have established a method for the specific induction of metabolically distinct obesity
phenotypes in zebrafish. Our results indicate that zebrafish represents an attractive model to study regulatory
mechanisms involved in the determination of AT phenotype during development of metabolically healthy versus
metabolically unhealthy obesity.
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Background
Obesity is characterized by an increase in adipose tissue
(AT) accumulation in presence of positive energy balance
and is a risk factor for metabolic and cardiovascular diseases,
and premature mortality [1–3]. Depending on body fat dis-
tribution and AT phenotype obese individuals differ in
their susceptibility to obesity-associated diseases, such as
hepatic steatosis and type 2 diabetes [4–6]. Compared to
the metabolically healthy obese (MHO) phenotype, which
is characterized by a beneficial AT distribution and AT
phenotype, the metabolically unhealthy obese (MUO)
phenotype shows a deleterious AT distribution and pheno-
type with more visceral fat, bigger adipocyte size, and in-
flammatory processes [7]. However, the identification of
mechanisms involved in the determination of body fat dis-
tribution and/or AT phenotype during obesity develop-
ment are limited by the lack of suitable in vivo models, in
which metabolically healthy versus metabolically un-
healthy AT accumulation can be specifically induced.
Recently, the zebrafish (Danio rerio) has emerged as an al-
ternative vertebrate model for the study of lipid metabolism
and metabolic diseases, such as obesity, type 2 diabetes and
hepatosteatosis [8, 9]. Organs and tissues of zebrafish are simi-
lar to those of humans in structure and function [10], and
regulation of energy homeostasis at the neural and endocrine
level is conserved [8, 11]. Moreover, diet-induced obesity in
zebrafish shares common pathophysiological pathways with
obesity in mammals [12–15]. Because of this, the zebrafish
has become increasingly important for the identification of
genes or potential drugs regulating lipid metabolism, AT ac-
cumulation and associated processes [9, 16].
We aimed to establish the zebrafish as a model for the ana-
lyses of mechanisms involved in the development of MUO or
MHO, respectively. To this end, we evaluated different
models of short-term diet-induced obesity by overfeeding of
adult zebrafish with normal fat or high fat diet, respectively,
and assessed the effect on AT accumulation, AT phenotype
and the occurrence of associatedmetabolic alterations.
Methods
Zebrafish husbandry
Zebrafish were raised and maintained at 28 °C at a 14 h light
: 10 h dark cycle. All animal experiments were performed ac-
cording to European guidelines and approved by the local
ethics committee (Landesdirektion Sachsen, Germany).
Zebrafish feeding experiments
For feeding experiments, male zebrafish of the AB strain were
used.We chose to use the AB strain for two reasons: First, the
AB strain is widely used by the zebrafish research community
and is frequently used for mutagenesis screens and gene
knockdown approaches because embryonic lethals have been
removed from the population allowing a more productive
screen for embryonic phenotypes [17]. Second, among all
strains available the AB strain has been most frequently used
to study obesity and obesity-related processes in zebrafish
[14, 15, 18, 19]. Male AB zebrafish were assigned to three
dietary groups: One group was fed with peeled Artemia
salina cysts (22% fat, 44% proteins, 16% carbohydrates; Aqua
Schwarz) in a weight-maintaining amount (control; 5mg arte-
mia per fish per day), another group was overfed with artemia
to induce an obese state under normal-fat-diet conditions
(NFD-OF, 60 mg artemia) [14], and a third group was fed a
combination of artemia (5 mg artemia) and egg yolk powder
(59% fat, 32% proteins, 2% carbohydrates; Sigma; 30 mg)
mimicking a high-fat-diet (HFD-OF) in an isocaloric amount
compared to NFD-OF. Zebrafish were maintained at 10 fish
per 3 L-tank and fed once per day. At week 8, zebrafish were
fasted overnight and sacrificed. The feeding protocol used
in this study was adapted from a previous study by Oka et
al. showing that 5 mg artemia per day corresponds to the
physiological energy requirement of an adult zebrafish [14].
Three independent feeding experiments were performed
over a period of 18 months. Age of zebrafish included in
each of the independent experiments was 92 days post
fertilization (dpf), 99 dpf and 179 dpf, respectively, which
corresponds to 3-6months post fertilization (mpf).
Before the start (week 0) and at the end (week 8) of the feed-
ing experiment, body weight and length of anaesthetized zeb-
rafish was recorded, and body mass index (BMI) and Fulton’s
condition index were calculated. Since we analysed 10 fish per
tank individual tracking of fish during feedingwas not possible
and bodyweight, length and related parameters were averaged
per tank. To exclude an effect of developmental and growth
variations on our results, feeding groups were matched ac-
cording to body length and body weight. Weight was deter-
mined every two weeks during the experiment without
anaesthesia to preclude a bias of results by frequent anaesthe-
sia. At week 8, body fat percentage was analysed using an
EchoMRI 4in1 (EchoMRITM). Fasting blood glucosewasmea-
sured from the dorsal artery using a glucose meter (FreeStyle
FreedomLite, Abbott). For analyses of plasma triglyceride and
cholesterol levels, blood samples were collected from the dor-
sal artery and pooled from all zebrafish per feeding group for
one exemplary feeding experiment. Blood samples were cen-
trifuged and plasma was collected from the supernatant. Tri-
glyceride levels were determined using the LabAssay™
Triglyceride kit (Wako) and cholesterol levels were deter-
mined using the Amplex® Red cholesterol Assay Kit (Invitro-
gen) according to themanufacturer’s instruction.
Magnetic resonance imaging (MRI)
MRI experiments were performed on a Bruker Advance DRX
300 MHz NMR spectrometer equipped with a 2.5 micro im-
aging unit (Bruker). Prior to theMRI measurements, the zeb-
rafish were sacrificed, fixed in 2% (w/v) low melting agarose
solution with 10% (w/w) sodium chloride. In order to deter-
mine the position of the fish, a TRIPILOT FLASH sequence
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was used for overview scans. A field of view of 16 x 16 x
250 mm was chosen to include the whole fish. The FOV was
divided into 50 axial slices of 0.5 mm thickness. The plane
resolution was set to 128 x 128 resulting in a voxel size of
7.81 mm3. Of each axial slice a fat and a water image were
taken using a chemical excitation selective (CHESS) sequence.
Water was excited by a frequency selective 300 Hz Gaussian
pulse and fat by a 1 kHz EBURP pulse set on resonance re-
spectively. In both cases a 4.6 kHz Sinc pulse was used for slice
selective refocusing. Image processing was performed by an
in-house written Python 2.7 script.
In preliminary analyses, we compared body fat quantifica-
tion based onMR imaging and Echo-MRI 4in1 measurement
using 8 adult male AB zebrafish at 6 months post fertilization.
For this, MR images were background corrected based on the
noise distribution and the intensity was scaled by the corre-
sponding receiver gain. Calculation of the fat-water ratio was
performed for each pixel. Based on the fat-water ratio the fat
volume per voxel was determined. Fat mass was calculated
and compared to fat mass directly measured by Echo-MRI
4in1 (EchoMRI™). In fact, we detected a strong and significant
correlation between the two approaches (Fig. 1).
Histology
Whole Zebrafish were fixed in 4% paraformaldehyde, embed-
ded in paraffin and cross-sectioned. Anatomically comparable
sections of the subcutaneous and visceral region were stained
with haematoxylin-eosin andmicroscopic images at 40xmag-
nification were obtained. Image analyses were performed
using ImageJ software (National Institutes of Health) [20–
22]. In particular, for each fish subcutaneous and visceral
adipocytes per field of view were counted and the cell area
of each adipocyte was manually measured.
For preparation of cryosections from zebrafish liver, freshly
isolated liver tissue was embedded in Tissue-Tek (Sakura
Finetek), frozen at -80 °C, and cut using a cryostat (Thermo
Scientific). Sections were dried, fixed in 4% paraformalde-
hyde, stained with Oil-Red-O, and analysed by microscopy.
RNA isolation and mRNA expression analyses
Visceral AT and liver were homogenized in TRIzol re-
agent (Thermo Fisher Scientific) and total RNA was iso-
lated from the aqueous phase using the RNeasy Mini Kit
(Qiagen). 500 ng of RNA were reverse transcribed into
cDNA using M-MLV Reverse Transcriptase (Invitrogen)
and random hexamer primers (Promega). Quantitative
real-time RT-PCR was performed as described [23]. Pri-
mer and probe sequences are listed in Table 1.
Protein isolation and immunoblot analyses
Proteins were isolated from the organic phase of the TRIzol
(Thermo Fisher Scientific) tissue lysate, which was a side
product from the RNA isolation procedure. Proteins were
precipitated according to the manufacturer’s instructions.
Equivalent amount of proteins were resolved by 10% SDS-
PAGE and immunoblotting using antibodies directed
against P-Akt (Thr308 for human Akt corresponding to
Thr307 for zebrafish Akt, 244 F9; cat. no. 4056, Cell Signal-
ing), total Akt (cat. no. 9272, Cell Signaling) and beta-Actin
(cat. no. ab8227, abcam). Protein levels of P-Akt and total
Akt were analyzed using ImageJ software (National Insti-
tutes of Health) and the ratio was calculated.
Statistical analyses
Each feeding experiment was independently repeated two
times. Statistical analyses were performed using GraphPad
Prism 5 (GraphPad Software). Statistical tests used for
each analysis are indicated in the figure legends.
Results
We assessed diet-induced obesity in zebrafish by overfeed-
ing adult male zebrafish with normal-fat-diet (NFD-OF)
or high-fat-diet (HFD-OF) compared to physiological
control diet for 8 weeks (Fig. 2a). Both, NFD-OF and
HFD-OF fish had an enlarged belly compared to control
fish (Fig. 2b). Control zebrafish maintained their weight
during the 8-week feeding experiment. While fish in the
NFD-OF group almost doubled their weight, the weight
gain of HFD-OF fish was not as prominent (Fig. 2c). The
weight gain observed under overfeeding conditions was
accompanied by an increased growth in both groups
Fig. 1 Comparison of methods for determination of body fat mass
in adult zebrafish. Comparison of body fat mass (mg) determined by
analyses of MR images (Bruker) and by EchoMRI 4in1 measurement
(EchoMRI™) in 8 adult, male zebrafish of the AB strain at 6 months
post fertilization showed a strong correlation between the two
methods. Squared Pearson correlation coefficient R2 and p-value are
shown in the scatter plot. NFD, normal fat diet; HFD, high-fat-diet; OF,
overfeeding; MRI, Magnetic Resonance Imaging; AT, adipose tissue
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(Fig. 2d). Both NFD-OF and HFD-OF fish showed a sig-
nificant increase in body mass index (BMI, Fig. 2e) and
Fulton’s condition index (Fig. 2f), which was considerably
higher in NFD-OF compared to HFD-OF fish. Body fat
percentage was increased in both NFD-OF and HFD-OF
fish but did not significantly differ between the OF groups
(Fig. 3a). HFD-OF but not NFD-OF fish showed signifi-
cantly elevated blood glucose levels compared to control
zebrafish (Fig. 3b) and presented significantly elevated
plasma triglyceride (Fig. 3c) and cholesterol (Fig. 3d) levels
as well as a prominent ectopic accumulation of lipids in
liver (Fig. 3e) and muscle (Fig. 3f). In line with this, immu-
noblot analysis of phospho-Akt and total Akt protein
levels in liver lysates demonstrated higher levels of
phospho-Akt in HFD-OF zebrafish compared to NFD-OF
or control zebrafish indicating an early state of insulin re-
sistance (Fig. 3g). Analyses of fat distribution by MRI and
haematoxylin-eosin staining of zebrafish cross sections re-
vealed an increase in both subcutaneous and visceral AT
in NFD-OF and HFD-OF compared to control zebrafish
(Fig. 3f). Both, NFD-OF and HFD-OF groups showed a
tendency towards an increase in adipocyte number in vis-
ceral AT. In subcutaneous AT adipocyte number was sig-
nificantly increased in NFD-OF fish, while there was only
a marginal increase in adipocyte number in HFD-OF fish
(Fig. 3h). Visceral and subcutaneous adipocytes were sig-
nificantly larger in NFD-OF and HFD-OF compared to
control fish. Importantly, HFD-OF zebrafish had larger
visceral but smaller subcutaneous adipocytes compared to
NFD-OF zebrafish indicating the presence of a metabolic-
ally unhealthy AT phenotype (Fig. 3i).
To assess the molecular differences between NFD-OF
and HFD-OF fish in AT and liver in more detail, we de-
termined the expression of marker genes for lipid stor-
age and inflammation, which had been previously
associated with different obesity phenotypes in rodents
and humans [24]. Due to the small amount of subcuta-
neous AT especially in control zebrafish, we had to re-
strict the analyses of marker gene expression to visceral
AT. In visceral AT, we did not detect significant alter-
ations in the expression of the adipocyte differentiation
marker pparg after overfeeding with NFD (NFD-OF) or
HFD (HFD-OF). However, in HFD-OF fish pparg was
significantly lower compared to NFD-OF fish. Further-
more, we analysed expression of the lipid storage
markers fabp11a, which is the zebrafish ortholog of hu-
man FABP4 [25–27], as well as fasn and srebf1, which is
an upstream regulator of fasn expression. While fabp11a
expression was only slightly increased in response to over-
feeding, fasn and srebf1 were upregulated in NFD-OF but
not altered in HFD-OF fish. Similarly, expression of lpl,
which is a lipoprotein lipase and a central regulator in
lipid metabolism, was significantly higher in NFD-OF zeb-
rafish but remained unchanged in HFD-OF zebrafish
Table 1 Primer and probe sequences for quantitative real-time RT-PCR






fabp11a fatty acid binding protein 11a TAQMAN F 5‘-GGTTGACAAATTCGTAGGAACGT
R 5‘-AACCCACACCTATAGCCTTCATG
AATGACCACCAGCGACAACTTTGACGA
fasn fatty acid synthase TAQMAN F 5‘-ACACGGTTCACGCATTTGTG
R 5‘-GACCCATCTTCCGTAGCATATCA
AGCTATTCAGGTTGCCCAGA




atgl adipose triglyceride lipase SYBR Green F 5‘-GCGTGACGGATGGAGAAA
R 5‘-AGGCCACAGTAAACAGGAATAT
hsl hormone-sensitive lipase SYBR Green F 5‘-CGGCAAGGACAGGACAGT
R 5‘-GCATGGAGAAAGAGGAGCT
lpl lipoprotein lipase TAQMAN F 5‘-CTGAGGGCTCTCGTTCATAAAGA
R 5‘-AATCCATCAAAGACTGTAACTTCAATACA
CTCTCAAACATACCCGTGACCGTCCATC
il1b interleukin 1 beta TAQMAN F 5‘- TCATCGCCCTGAACAGAATG
R 5‘-TCACTTCACGCTCTTGGATGAC
AGCACATCAAACCCCAATCCACAGAGTT
tnfa tumor necrosis factor alpha TAQMAN Predesigned
(Dr03126848_g1; Thermo Fisher)
col1a1a collagen, type I, alpha 1a SYBR Green F 5‘-GCTTTTGGCAAGAGGACAAG
R 5‘-TGTCTTCGCAGATCACTTCG
bactin2 beta-actin 2 TAQMAN F 5‘-TCCCCTTGTTCACAATAACCTACTAA
R 5‘-CATACCGGAGCCGTTGTCA
AGCGATTTCCTCATCCATGGCTGTGT
tbp TATA-box binding protein TAQMAN F 5‘-CCTGCGAATTATCGTTTACGTCTT
R 5‘-ACGGCATCATAGGACTGAAAATG
TTGCTTCATAACCTGTCAGCATGGAGCA
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compared to the control group. In contrast, expression of
the lipases atgl and hsl was not affected by NFD and HFD
overfeeding. Analyses of the inflammatory markers il1b
and tnfa revealed a tendential upregulation of il1b in
HFD-OF fish indicating slightly increased AT inflamma-
tion, while tnfa remained unchanged (Fig. 4a). Analyses of
Fig. 2 Overfeeding of adult zebrafish with either NFD or HFD leads to an obese phenotype. a Schematic overview of the 8-week feeding protocol
and phenotyping of zebrafish. b Exemplary images of zebrafish included in each of the analyzed dietary groups at week 8 of feeding. Black arrows
point to the abdominal region. Overfeeding of zebrafish with either NFD or HFD resulted in a significant increase in weight (c), standard length
(d), BMI (e), and Fulton’s condition index (f) compared to control zebrafish. Statistical analyses were performed using Two-Way ANOVA and Bonferroni
post-test and significant p-values are indicated. *, p < 0.05; **, p < 0.01; ***, p < 0.001; NFD, normal fat diet; HFD, high-fat-diet; OF, overfeeding; BMI, body
mass index; MRI, Magnetic Resonance Imaging; AT, adipose tissue
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the liver expression profile showed significantly increased
fabp11a expression in HFD-OF but not NFD-OF
zebrafish. Moreover, fasn expression in the liver was up-
regulated in NFD-OF but significantly downregulated in
HFD-OF when compared to control zebrafish. In line with
these data, srebf1 was increased in NFD-OF and decreased
in HFD-OF fish when compared with control fish. Expres-
sion of the lipases atgl, hsl and lpl and the inflammatory
Fig. 3 Phenotypic characterization of diet-induced obesity in zebrafish. Overfeeding of zebrafish with either NFD or HFD resulted in a significant
increase in body fat percentage (a) compared to control zebrafish. HFD-OF but not NFD-OF zebrafish showed significantly elevated fasting blood
glucose levels (b), triglyceride levels (c) and cholesterol levels (d), and a prominent accumulation of lipids in the liver as indicated by Oilred-O
staining of liver sections (e). Fat distribution was analyzed by MRI and hematoxylin-eosin staining of zebrafish cross sections and revealed an
increase in the amount of both subcutaneous and visceral AT in NFD-OF and HFD-OF compared to control zebrafish (f). Exemplary images of
zebrafish included in each of the analyzed dietary groups at week 8 of feeding are shown. Asterisk indicates intramuscular fat deposition in
HFD-OF fish. Immunoblot analyses of liver lysates showed increased phosphorylation of Akt at Thr307 (Thr308 in human) in HFD-OF compared
to NFD-OF and control zebrafish. The ratio of P-Akt to total Akt was analyzed using ImageJ software and is given underneath the immunoblot
images (g). Detection of β-Actin served as loading control. Visceral and subcutaneous adipocyte number and adipocyte size were determined
from hematoxylin-eosin-stained zebrafish sections using ImageJ software and were increased after overfeeding with NFD or HFD (h, i). Statistical
analyses were performed using One-Way ANOVA and Bonferroni post-test and significant p-values are indicated. *, p < 0.05; **, p < 0.01; ***, p < 0.001;
Scale bar in (h) represents 50 μm, Scale bar in (i) represents 100 μm; NFD, normal fat diet; HFD, high-fat-diet; OF, overfeeding; BMI, body mass index;
MRI, Magnetic Resonance Imaging; AT, adipose tissue
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marker il1b was not changed in fish included in the NFD-OF
or HFD-OF group. In contrast, tnfa expression in the liver
was increased under both overfeeding conditions. In
addition, col1a1a expressionwas increased only in response
to HFD but not NFD overfeeding suggesting the presence
of fibrosis in the liver of HFD overfed zebrafish (Fig. 4b).
Discussion
We show here that overfeeding of adult zebrafish with ei-
ther NFD or HFD results in an increase in body weight,
which is at least partially due to an increased accumula-
tion of body fat. Interestingly and importantly, the bio-
logical and metabolic phenotypes differ depending on the
type of the diet. In contrast to NFD-overfed zebrafish,
HFD-overfed zebrafish present adipocyte hypertrophy,
especially in the visceral AT depot, ectopic lipid accu-
mulation in the liver, and hyperglycaemia and crucial
differences in the expression of marker genes for lipid
metabolism, inflammation and fibrosis,– hence a
phenotype commonly referred to as MUO.
Different models of diet-induced obesity in zebrafish pro-
vided evidence that the pathophysiological pathways under-
lying diet-induced obesity in zebrafish are comparable to that
of mammals [13, 14]. Most of those studies compared lean
and obese animals andwere based on excessive overfeeding of
adult zebrafish with their “natural” diet in aquaculture condi-
tions, i.e. flakes or artemia. We have substantially extended
the published protocols by subjecting zebrafish to specific di-
ets, i.e. NFDorHFD, over an 8-week-period. Our results show
that dependent on the type of diet, one can not only induce
obesity but also specifically trigger the development of a
MHO versus a MUO AT phenotype as indicated by crucial
differences in numbers and sizes of subcutaneous and visceral
adipocytes, blood glucose, triglyceride and cholesterol levels,
liver lipid accumulation and transcript levels of lipid metabol-
ism and inflammationmarkers.
Compared with theMHOphenotype, theMUO phenotype
is associated with characteristic alterations in the metabolic
and immune function in humanAT.These alterations include
decreased expression of genes involved in lipid metabolism
Fig. 4 Diet-induced obesity is accompanied by characteristic alterations in AT and liver marker genes. Expression of marker genes for lipid metabolism
(pparg, fabp11a, fasn, srebf1, atgl, hsl, lpl), inflammation (il1b, tnfa) and fibrosis (col1a1a) was analyzed in visceral AT (a) and liver (b) after 8-week
overfeeding of adult male zebrafish with NFD or HFD. Induction of obesity by NFD-OF and HFD-OF resulted in characteristic alterations in
metabolic, inflammatory and fibrotic marker gene expression in visceral AT and liver of zebrafish. Data show results from 3 independent feeding
experiments and are given as mean ± SEM. Statistical analyses was performed by One-Way ANOVA and Bonferroni post-test and significant
p-values are indicated. *, p < 0.05; AT, adipose tissue; NFD, normal fat diet; HFD, high fat diet; OF, overfeeding
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and increased expression ofmarkers of AT inflammation [28].
Similarly to human studies, we observed a significant down-
regulation in the AT expression of several marker genes in-
volved in lipid metabolism including pparg, fasn and lpl in
HFD-OF compared to NFD-OF zebrafish. However, based on
the striking increase in fasn expression we observed in both
ATand liver upon overfeeding of zebrafish with a normal fat
diet one would have expected a similar increase in srebf1 ex-
pression, which is an upstream transcription factor regulating
fasn expression. However, fasn expression is not only regu-
lated by Srebf1 but also by other upstream regulators, such as
Usf [29]. Hence, we cannot exclude that these factors exert an
additional impact on fasn expression. Nevertheless, the fact
that we observed increased AT lpl expression in NFD-OF but
not in HFD-OF fish further supports ourmodel for the induc-
tion of metabolically distinct obesity phenotypes in zebrafish.
Previous data suggested that lpl expression and activity in
obese subjects are downregulated in an insulin-resistant com-
pared to an insulin-sensitive state [30, 31], and that an increase
of lipoprotein lipase in adipocytes improves glucose metabol-
ism inHFD-induced obesity [32].
We observed an increase in plasma triglyceride and chol-
esterol levels and ectopic liver lipid accumulation in zebra-
fish overfed with HFD compared to zebrafish overfed with
NFD. These results point to distinct metabolic phenotypes
of the two groups. However, the difference in blood glucose
levels between the groups was only modest and might re-
flect the short duration of the study. We assume that this
modest increase in blood glucose might represent early
obesity-related alterations in glucose metabolism but not a
manifestation of the disease. In fact, this assumption is
underlined by the results from immunoblot analyses show-
ing enhanced Thr308 phosphorylation of Akt (Thr307 for
the zebrafish protein) in the HFD-OF group. Unfortunately,
we cannot provide data on Ser473 phosphorylation of Akt
since we were lacking an antibody specifically detecting the
zebrafish protein. Furthermore, it would be interesting to
analyse how Akt phosphorylation in liver tissue of zebrafish
subjected to NFD and HFD overfeeding is affected by an in-
sulin challenge. Both, enhanced Thr308 and Ser473 phos-
phorylation of Akt have been associated with an early state
of insulin resistance upon HFD overfeeding [33–36]. In our
opinion, the observation of increased Thr308 phosphoryl-
ation of Akt in liver tissue upon HFD overfeeding might
represent a valuable strength of the study protocol allowing
the analyses of obesity-related alterations in AT and liver
which occur with ATaccumulation before or during the de-
velopment of obesity-related metabolic alterations. Hence,
the model described in this study provides a unique tool to
study physiological mechanisms involved in maintaining or
disrupting metabolic health in obesity. The better under-
standing of these mechanisms might enhance the identifi-
cation of novel therapeutic approaches specifically
targeting the metabolic phenotype of obese patients. In this
context, the zebrafish might be a particularly well-suited
model organism. They share a considerable amount of gen-
etic identity with humans and sophisticated mutagenesis,
transgenesis, and screening strategies are available and can
be used with an economy that is not possible in other verte-
brates [10].
It should be noted that for the establishment of the
short-term feeding protocol described in this study, we
used male zebrafish only. Previous short-term and long-
term analyses suggested that female zebrafish show a
similar response to diet-induced obesity compared to
male zebrafish with increased body length, body weight
and BMI although to different extent [13, 14]. Reason
for this might be that female zebrafish constantly pro-
duce eggs, which contain large amounts of lipids. In fact,
it has been demonstrated that in adult female zebrafish
ovaries can account for up to 29% of body weight com-
pared to less than 2% for the testis in male zebrafish
[13]. Because of this measurement of weight and body
fat content in female adult zebrafish does not necessarily
reflect AT accumulation but may be an indicator of oo-
cyte growth as well. Since all zebrafish included in this
study were either histologically analysed or subjected to
organ preparation for expression analyses we can ex-
clude that the occurrence of diet-induced sex reversal as
a potential bias. It might be of interest for future studies
to analyse whether the here provided feeding protocol is
informative for both sexes. In this regard, the analysis of
never-mated female zebrafish might provide important
information on the transferability of the method to fe-
male zebrafish. Furthermore, obesity development and
progression might be influenced by the age of fish, the
genetic background and the body weight state at the
start of the experiment. The here described protocol was
established using 3 to 6 months old zebrafish of the AB
strain. For the use of a different zebrafish strain, such as
Tu, TL or WIK, specific parameters such as amount of
food or duration of feeding experiment may need to be
adjusted. Given the simplicity of the feeding protocol
and the detailed phenotypic characterization described
in our study, we believe that it can be easily applied to
answer the questions whether sex, age or genetic back-
ground of zebrafish influence the response to NFD and
HFD overfeeding and the associated development of
metabolically distinct obesity phenotypes.
Our study is strengthened by the extensive phenotypic
characterization including determination of total body
fat content, adipocyte numbers and sizes in both sub-
cutaneous and visceral AT, blood glucose, triglyceride
and cholesterol levels, ectopic lipid accumulation in the
liver and expression levels of marker genes for lipid me-
tabolism and inflammation, which allows the identifica-
tion of diet-dependent metabolically distinct obesity
phenotypes.
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Conclusions
In summary, we have established a protocol for the induc-
tion of MHO versus MUO in zebrafish providing an at-
tractive model to study regulatory mechanisms underlying
the determination of distinct obesity-related AT pheno-
types and metabolic state.
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